Status: Active

Cardiac Success

  • Status Current
  • Sector Heart Failure
  • Year Invested 2021
  • HQ Yokne'am Illit, Israel
  • Clinical Operations Israel, Poland, Georgia
  • Lead Partners Ruben Osnabrugge


Related News

Percutaneous Ventricular Repair Technology to treat Heart Failure (HFrEF)

Cardiac Success is developing the V-sling device to improve the lives of the millions of patients who, despite guidance-directed medical therapy, continue to suffer and deteriorate from Heart Failure with Reduced Ejection Fraction (HFrEF). The V-sling is a transcatheter ventricular repair device designed based on a successful surgical papillary muscle approximation procedure.